Symbol="ONCT"
AssetType="Common Stock"
Name="Oncternal Therapeutics Inc"
Description="Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of cancer therapies for cancers with critical unmet medical needs. The company is headquartered in San Diego, California."
CIK="1260990"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12230 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18446400"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="0.894"
DividendPerShare="0"
DividendYield="0"
EPS="-0.83"
RevenuePerShareTTM="0.017"
ProfitMargin="0"
OperatingMarginTTM="-49.82"
ReturnOnAssetsTTM="-0.41"
ReturnOnEquityTTM="-0.69"
RevenueTTM="947000"
GrossProfitTTM="-31490000"
DilutedEPSTTM="-0.83"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.728"
AnalystTargetPrice="1.9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.64"
PriceToBookRatio="0.879"
EVToRevenue="0.853"
EVToEBITDA="0.249"
Beta="1.363"
num_52WeekHigh="1.4"
num_52WeekLow="0.26"
num_50DayMovingAverage="0.371"
num_200DayMovingAverage="0.693"
SharesOutstanding="58728000"
DividendDate="2019-06-10"
ExDividendDate="None"
symbol="ONCT"
open="0.29"
high="0.33"
low="0.29"
price="0.31"
volume="247230.00"
latest_trading_day="2023-08-11"
previous_close="0.34"
change="-0.02"
change_percent="-7.3451%"
aroon_positive_momentum_days="30"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="450611"
Change_recent_avg="0.01"
Delta_recent_avg="0.04"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_30"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="692"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
